
zzso growth factor zzso zzso treatment has been successfully applied in clinical cancer zzso However, the clinical efficacy of first-generation zzso zzso zzso such as zzso and zzso is limited by the development of drug-resistant zzso including the gatekeeper zzso zzso and zzso of alternative signaling zzso zzso irreversible zzso zzso that were designed to overcome the drug resistance due to the zzso zzso have thus far had limited zzso Here, we report a novel zzso zzso zzso zzso which has potent activity against zzso with zzso and zzso zzso zzso In addition, zzso has also considerable zzso potency against some other related zzso including zzso zzso and zzso zzso 2 zzso zzso exhibited highly zzso activity against a range of zzso cell lines, including zzso and zzso cell lines, and zzso or zzso cell zzso zzso also showed a potent zzso effect in zzso in a zzso embryonic zzso zzso and in an zzso tumor cell zzso In zzso oral administration of zzso showed complete tumor zzso in zzso zzso and zzso zzso models and showed a considerable zzso effect on the zzso zzso model as well as other zzso or zzso tumor models including zzso zzso and zzso established in zzso zzso zzso also showed a very good oral zzso zzso zzso these zzso evaluations may support clinical development of zzso for zzso with zzso zzso or zzso zzso 

